Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics

Cancer is a complex disease; glioblastoma (GBM) is no exception. Short survival, poor prognosis, and very limited treatment options make it imperative to unravel the disease pathophysiology. The critically important identification of proteins that mediate various cellular events during disease is ma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Physiol Genomics
Autors principals: Heroux, Maxime S., Chesnik, Marla A., Halligan, Brian D., Al-Gizawiy, Mona, Connelly, Jennifer M., Mueller, Wade M., Rand, Scott D., Cochran, Elizabeth J., LaViolette, Peter S., Malkin, Mark G., Schmainda, Kathleen M., Mirza, Shama P.
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2014
Matèries:
General Interest
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587597/
https://ncbi.nlm.nih.gov/pubmed/24803679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/physiolgenomics.00034.2014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars